- Presentations
- 6
- Markets
- 2
Emend is a brand of Fosaprepitant and Aprepitant marketed by Merck Sharp & Dohme, with 6 presentations listed and registered in European Union, United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Fosaprepitant, Aprepitant
- Brand owner
- Merck Sharp & Dohme
- Registered in
- European Union, United States
- Strengths and forms
- 125 mg capsule, 40 mg capsule, 80 mg capsule, kit, 150 mg/5 mL powder for injection, 125 mg powder for oral suspension
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Emend 125 mg capsuleOral | Merck Sharp & Dohme | US FDA | Available on request |
| Emend 40 mg capsuleOral | Merck Sharp & Dohme | US FDA | Available on request |
| Emend 80 mg capsuleOral | Merck Sharp & Dohme | US FDA | Available on request |
| Emend kit | Merck Sharp & Dohme | US FDA | Available on request |
| Emend 150 mg/5 mL powder for injectionIntravenous Cold chain | Merck Sharp & Dohme | US FDA | Available on request |
| Emend 125 mg powder for oral suspensionOral | Merck Sharp & Dohme | US FDA | Available on request |
Equivalent brands
Other brands of Fosaprepitant and Aprepitant.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Emend
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.